![](/img/cover-not-exists.png)
Randomized phase II evaluation of preoperative radiation therapy (XRT) and chemotherapy with mitomycin-C, vinblastine, and cisplatin (MVP) for patients with pathologic stage IIIA and IIIB non-small cell lung cancer (NSCLC)
Henry Wagner Jr., Thomas Lad, John C. RuckdeschelVolume:
19
Year:
1990
Language:
english
DOI:
10.1016/0360-3016(90)90691-c
File:
PDF, 118 KB
english, 1990